206 related articles for article (PubMed ID: 2548865)
1. Quality control parameters and interpretive criteria for in vitro susceptibility tests with the macrolide azithromycin. Collaborative Antimicrobial Susceptibility Testing Group.
Barry AL; Thornsberry C; Gavan TL
Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):544-9. PubMed ID: 2548865
[TBL] [Abstract][Full Text] [Related]
2. Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria.
Fuchs PC; Jones RN; Barry AL; Gavan TL
J Clin Microbiol; 1989 Jan; 27(1):49-52. PubMed ID: 2492304
[TBL] [Abstract][Full Text] [Related]
3. Dirithromycin disc susceptibility tests: interpretative criteria and quality control parameters.
Barry AL; Pfaller MA; Fuchs PC
J Antimicrob Chemother; 1993 Mar; 31 Suppl C():27-37. PubMed ID: 8478310
[TBL] [Abstract][Full Text] [Related]
4. Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporin.
Jones RN; Barry AL
J Clin Microbiol; 1987 Nov; 25(11):2211-3. PubMed ID: 3121667
[TBL] [Abstract][Full Text] [Related]
5. Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium. National Committee for Clinical Laboratory Standards.
Jones RN; Doern GV; Gerlach EH; Hindler J; Erwin ME
Diagn Microbiol Infect Dis; 1994 Apr; 18(4):243-9. PubMed ID: 7924221
[TBL] [Abstract][Full Text] [Related]
6. Development of interpretive criteria and quality control limits for macrolide and clindamycin susceptibility testing of Streptococcus pneumoniae.
Jorgensen JH; Swenson JM; Tenover FC; Barry A; Ferraro MJ; Murray PR; Reller LB
J Clin Microbiol; 1996 Nov; 34(11):2679-84. PubMed ID: 8897164
[TBL] [Abstract][Full Text] [Related]
7. Interpretive criteria and quality control limits for ceftibuten disk susceptibility tests. Collaborative Antimicrobial Susceptibility Testing Group.
Barry AL; Jones RN
J Clin Microbiol; 1990 Mar; 28(3):605-7. PubMed ID: 2182675
[TBL] [Abstract][Full Text] [Related]
8. Quality control limits for teicoplanin susceptibility tests and confirmation of disk diffusion interpretive criteria.
Barry AL; Jones RN; Gavan TL; Thornsberry C
J Clin Microbiol; 1987 Sep; 25(9):1812-4. PubMed ID: 2958498
[TBL] [Abstract][Full Text] [Related]
9. Interpretive criteria and quality control for antimicrobial susceptibility tests of levofloxacin.
Barry A; Fuchs P; Tenover F; Allen S; Hardy D; Jorgensen J; McLaughlin J; Reller L
Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):822-6. PubMed ID: 7889952
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility testing quality control studies with fosfomycin tromethamine.
Fuchs PC; Barry AL; Brown SD
Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):538-40. PubMed ID: 9272392
[TBL] [Abstract][Full Text] [Related]
11. Interpretive criteria and quality control parameters for determining bacterial susceptibility to fosfomycin tromethamine.
Barry AL; Pfaller MA; Fuchs PC; Tenover FC; Reller LB; Allen SD; Hardy DJ; Gerlach EH
Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):352-6. PubMed ID: 8354302
[TBL] [Abstract][Full Text] [Related]
12. Disk diffusion susceptibility testing of two macrolide antimicrobial agents: revised interpretive criteria for erythromycin and preliminary guidelines for roxithromycin (RU 965).
Jones RN; Barry AL; Fuchs PC; Thornsberry C
J Clin Microbiol; 1986 Aug; 24(2):233-9. PubMed ID: 3091634
[TBL] [Abstract][Full Text] [Related]
13. Interpretive criteria and quality control parameters for testing bacterial susceptibility to the fluoroquinolone PD131628.
Barry AL; Fuchs PC; Allen SD; Tenover FC; Jorgensen JH; Reller LB
J Clin Microbiol; 1995 Jan; 33(1):235-8. PubMed ID: 7699050
[TBL] [Abstract][Full Text] [Related]
14. Interpretive criteria and tentative quality control limits for apalcillin disk susceptibility tests.
Barry AL; Thornsberry C; Jones RN; Gavan TL
J Clin Microbiol; 1984 Jun; 19(6):777-82. PubMed ID: 6432833
[TBL] [Abstract][Full Text] [Related]
15. Quality control of susceptibility tests with 5-micrograms trimethoprim disks.
Barry AL; Jones RN; Gavan TL
J Clin Microbiol; 1984 Oct; 20(4):817-9. PubMed ID: 6436317
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility testing and quality control parameters for sarafloxacin (A-56620): a fluoroquinolone used for treatment and control of colibacillosis in poultry. Quality Control Study Group.
Jones RN; Erwin ME
Diagn Microbiol Infect Dis; 1998 Sep; 32(1):55-64. PubMed ID: 9791759
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of bovine mastitis pathogens to a combination of penicillin and framycetin: development of interpretive criteria for testing by broth microdilution and disk diffusion.
Pillar CM; Stoneburner A; Shinabarger DL; Abbeloos E; Goby L; Bradley AJ
J Dairy Sci; 2014 Oct; 97(10):6594-607. PubMed ID: 25129497
[TBL] [Abstract][Full Text] [Related]
18. Assessment of BMS284756 MIC and 5-microg disk diffusion quality control studies tested against seven American type culture collection strains.
Biedenbach DJ; Jones RN;
Diagn Microbiol Infect Dis; 2001 Dec; 41(4):225-8. PubMed ID: 11777665
[TBL] [Abstract][Full Text] [Related]
19. Quality control limits for microdilution susceptibility tests with norfloxacin.
Barry AL; Gavan TL; Ayers LW; Fuchs PC; Gerlach EH; Thornsberry C
J Clin Microbiol; 1987 Jan; 25(1):165-6. PubMed ID: 3098779
[TBL] [Abstract][Full Text] [Related]
20. Provisional quality control parameters and interpretive criteria for testing susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to quinupristin/dalfopristin (RP59500). Antimicrobial Testing Quality Control Group.
Fuchs P; Barry A; Brown S
Eur J Clin Microbiol Infect Dis; 1998 Mar; 17(3):197-201. PubMed ID: 9665303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
